Luye Pharma Group has announced its intention to acquire the transdermal drug delivery systems (TDS) business of Acino by purchasing the entire issued share capital of Acino AG and Acino Supply AG for a purchase price of €245m ($268.8m).
Luye Pharma marks a significant step in its international expansion strategy and enables it to explore broader therapeutic areas through the acquisition.
MED-ART has agreed to sell its 100% stake in Q-Med, an orthopedic product developer, to EMC Instytut Medyczny S.A. (EMC Instytut), a Polish healthcare services provider, for PLN7.7m ($2m).
EMC Instytut has also signed a preliminary agreement to completely own CM Medyk Sp. z o.o., which operates under the Aktywne Centrum Zdrowia (ACZ) brand.
Steris, a cleaning validation and infection prevention solutions provider has, completed the acquisition of Medisafe Holdings, a UK-based maker of washer / disinfector equipment, for approximately £27m ($35.68m).
Effective from 22 July 2016, the acquisition provides Steris with washer manufacturing and research and development capabilities in the UK, while Medisafe’s products complement its healthcare products segment.
Fujifilm Holdings Corporation has announced that it will acquire 70% stake in Wako Pure Chemical Industries from Takeda Pharmaceutical for a purchase consideration of approximately ¥100bn ($939.85m).
Once completed, the acquisition will help Fujifilm to improve its drug development capacity and to develop partnerships with operations that utilise regenerative medical technology.